235 related articles for article (PubMed ID: 28387640)
21. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
Ahn KJ; Hwang HS; Park JH; Bang SH; Kang WJ; Yun M; Lee JD
J Nucl Med; 2009 Sep; 50(9):1525-32. PubMed ID: 19690031
[TBL] [Abstract][Full Text] [Related]
22. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
Yamamoto Y; Nishiyama Y; Kameyama R; Okano K; Kashiwagi H; Deguchi A; Kaji M; Ohkawa M
J Nucl Med; 2008 Aug; 49(8):1245-8. PubMed ID: 18632827
[TBL] [Abstract][Full Text] [Related]
23. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Kitamura K; Ikai I; Uemoto S
Int J Oncol; 2009 May; 34(5):1303-12. PubMed ID: 19360342
[TBL] [Abstract][Full Text] [Related]
24. Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma.
Kobayashi T; Aikata H; Honda F; Nakano N; Nakamura Y; Hatooka M; Morio K; Morio R; Fukuhara T; Masaki K; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Ohdan H; Awai K; Chayama K
J Comput Assist Tomogr; 2016; 40(4):524-30. PubMed ID: 26966955
[TBL] [Abstract][Full Text] [Related]
25. F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
Wu HB; Wang QS; Li BY; Li HS; Zhou WL; Wang QY
Clin Nucl Med; 2011 Dec; 36(12):1092-7. PubMed ID: 22064078
[TBL] [Abstract][Full Text] [Related]
26. Prognostic values of ALDOB expression and
Jia W; Wu Q; Yu X; Shen M; Zhang R; Li J; Zhao L; Huang G; Liu J
Front Oncol; 2022; 12():1044902. PubMed ID: 36644641
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.
Yang J; Jin X; Yan Y; Shao Y; Pan Y; Roberts LR; Zhang J; Huang H; Jiang J
Sci Rep; 2017 Mar; 7():43864. PubMed ID: 28262837
[TBL] [Abstract][Full Text] [Related]
28. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
Bernstine H; Braun M; Yefremov N; Lamash Y; Carmi R; Stern D; Steinmetz A; Sosna J; Groshar D
Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
[TBL] [Abstract][Full Text] [Related]
29. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Lee JW; Paeng JC; Kang KW; Kwon HW; Suh KS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2009 May; 50(5):682-7. PubMed ID: 19372474
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
Park JH; Kang JH; Lee YJ; Kim KI; Lee TS; Kim KM; Park JA; Ko YO; Yu DY; Nahm SS; Jeon TJ; Park YS; Lim SM
Oncol Rep; 2015 Jan; 33(1):347-53. PubMed ID: 25371060
[TBL] [Abstract][Full Text] [Related]
31. GLUT1 expression in high-risk prostate cancer: correlation with
Meziou S; Ringuette Goulet C; Hovington H; Lefebvre V; Lavallée É; Bergeron M; Brisson H; Champagne A; Neveu B; Lacombe D; Beauregard JM; Buteau FA; Riopel J; Pouliot F
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):441-448. PubMed ID: 31932660
[TBL] [Abstract][Full Text] [Related]
32.
Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
[TBL] [Abstract][Full Text] [Related]
33. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
Lee M; Ko H; Yun M
Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847
[TBL] [Abstract][Full Text] [Related]
34. Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
Grabellus F; Nagarajah J; Bockisch A; Schmid KW; Sheu SY
Clin Nucl Med; 2012 Feb; 37(2):121-7. PubMed ID: 22228332
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib.
Lee JH; Park JY; Kim DY; Ahn SH; Han KH; Seo HJ; Lee JD; Choi HJ
Liver Int; 2011 Sep; 31(8):1144-9. PubMed ID: 21745288
[TBL] [Abstract][Full Text] [Related]
36. The role of 18F-FDG accumulation and arterial enhancement as biomarkers in the assessment of typing, grading and staging of hepatocellular carcinoma using 18F-FDG-PET/CT with integrated dual-phase CT angiography.
Ferda J; Ferdová E; Baxa J; Kreuzberg B; Daum O; Třeška V; Skalický T
Anticancer Res; 2015 Apr; 35(4):2241-6. PubMed ID: 25862885
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
Hyun SH; Eo JS; Lee JW; Choi JY; Lee KH; Na SJ; Hong IK; Oh JK; Chung YA; Song BI; Kim TS; Kim KS; Moon DH; Yun M
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1638-45. PubMed ID: 26936852
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
Shin DY; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
Cancer Chemother Pharmacol; 2011 Jul; 68(1):165-75. PubMed ID: 20872146
[TBL] [Abstract][Full Text] [Related]
39. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
[TBL] [Abstract][Full Text] [Related]
40. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study.
Ling LL; Hsu CC; Yong CC; Elsarawy AM; Chan YC; Wang CC; Li WF; Lin TL; Kuo FY; Cheng YF; Lin LM; Chen CL; Lin CC
Int J Surg; 2019 Sep; 69():124-131. PubMed ID: 31386913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
